Liquiritin

Liquiritin

SCHEMBL29536850

O=C1C[C@@H](c2ccc(O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)cc2)Oc2cc(O)ccc21

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TRPA1 O75762 1/20 1.00
▸ P4HB P07237 1/20 1.00
▸ TRPV1 Q8NER1 1/20 1.00
▸ PTPN1 P18031 4/20 0.70
▸ SLCO2B1 O94956 2/20 0.70
▸ SYNJ2 O15056 1/20 0.63
▸ XDH P47989 1/20 0.60
▸ KDM1A O60341 1/20 0.59
▸ CYP19A1 P11511 6/20 0.58
▸ TUBB4A P04350 1/20 0.58
▸ TUBB P07437 1/20 0.58
▸ YES1 P07947 1/20 0.58
▸ TUBA3C P0DPH7 1/20 0.58
▸ TUBA1B P68363 1/20 0.58
▸ TUBA4A P68366 1/20 0.58
▸ TUBB4B P68371 1/20 0.58
▸ TUBB3 Q13509 1/20 0.58
▸ TUBB2A Q13885 1/20 0.58
▸ TUBB8 Q3ZCM7 1/20 0.58
▸ TUBA3E Q6PEY2 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Liquiritin SCHEMBL13906116 1.00 TRPA1 (1.00) TRPA1P4HBTRPV1PTPN1SLCO2B1
Liquiritin SCHEMBL13931703 1.00 TRPA1 (1.00) TRPA1P4HBTRPV1PTPN1SLCO2B1
Liquiritin SCHEMBL26113334 1.00 TRPA1 (1.00) TRPA1P4HBTRPV1PTPN1SLCO2B1
Liquiritin SCHEMBL24209243 1.00 TRPA1 (1.00) TRPA1P4HBTRPV1PTPN1SLCO2B1
Liquiritin SCHEMBL15091079 1.00 TRPA1 (1.00) TRPA1P4HBTRPV1PTPN1SLCO2B1
Liquiritin SCHEMBL24835038 1.00 TRPA1 (1.00) TRPA1P4HBTRPV1PTPN1SLCO2B1
SCHEMBL29351306 0.94 TRPA1 (0.89) TRPA1P4HBTRPV1PTPN1SLCO2B1
SCHEMBL10926327 0.88 TRPA1 (0.79) TRPA1P4HBTRPV1PTPN1SLCO2B1
SCHEMBL27939664 0.88 TRPA1 (0.79) TRPA1P4HBTRPV1PTPN1SLCO2B1
SCHEMBL31504735 0.88 TRPA1 (0.79) TRPA1P4HBTRPV1PTPN1SLCO2B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250250647-A1 STABLE CELL CLONES HARBORING REPLICATING SARS-COV-2 RNA THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN (US) 2025-08-07 — — US disclosed
US-20250090435-A1 PRESERVATIVES FOR COSMETIC AND PHARMACEUTICAL COMPOSITIONS SACHEM, INC. (US) 2025-03-20 — — US disclosed
EP-4376798-A1 PRESERVATIVES FOR COSMETIC AND PHARMACEUTICAL COMPOSITIONS Sachem, Inc. (US) 2024-06-05 — — EP disclosed
CN-117813075-A Preservative for cosmetic and pharmaceutical compositions 赛成公司 2024-04-02 — — CN disclosed
WO-2023009849-A1 PRESERVATIVES FOR COSMETIC AND PHARMACEUTICAL COMPOSITIONS SACHEM, INC. (US) 2023-02-02 — — WO disclosed
US-20220088199-A1 METHOD FOR PROTECTING GLYCEROL ALKYL ETHERS FROM OXIDATION SACHEM, INC. 2022-03-24 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250090435-A1 PRESERVATIVES FOR COSMETIC AND PHARMACEUTICAL COMPOSITIONS PLOD2, CUTA, PHOSPHO1 TRPA1 545/4885P4HB 403/4885TRPV1 893/4885
US-20220088199-A1 METHOD FOR PROTECTING GLYCEROL ALKYL ETHERS FROM OXIDATION GK, ABHD10, CBR3 TRPA1 4173/4885P4HB 80/4885TRPV1 4188/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback